logo
Book a meeting
Galecto

Galecto

Biotechnology, 75 State St Ste 100, Copenhagen, Massachusetts, 02109, United States, 11-50 Employees

galecto.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 45********

Who is GALECTO

Galecto is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, infl...

Read More

lock icon Get Full Access
map
  • 75 State St Ste 100, Copenhagen, Massachusetts, 02109, United States Headquarters: 75 State St Ste 100, Copenhagen, Massachusetts, 02109, United States
  • 2011 Date Founded: 2011
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from GALECTO

Galecto Org Chart and Mapping

Employees
Lori Firmani

Lori Firmani

VP of Finance

Sylwia Urato

Sylwia Urato

Senior Director Fp&A and Accounting

See Full Org Chart arrow
email-formate-icon
View Email Formats for Galecto
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Galecto

Answer: Galecto's headquarters are located at 75 State St Ste 100, Copenhagen, Massachusetts, 02109, United States

Answer: Galecto's phone number is 45********

Answer: Galecto's official website is https://galecto.com

Answer: Galecto's revenue is $10 Million to $25 Million

Answer: Galecto's SIC: 2834

Answer: Galecto has 11-50 employees

Answer: Galecto is in Biotechnology

Answer: Galecto contact info: Phone number: 45******** Website: https://galecto.com

Answer: Galecto is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer. Galecto was founded by leading fibrosis-focused scientists and biotech executives and is built on more than 10 years of research into galectin and fibrosis modulators. Our team has developed a deep understanding of the galectin family of proteins and the LOXL2 enzyme, and how both influence multiple biological pathways of these complex, often devastating, diseases. Galecto is funded by Novo Holdings, OrbiMed, Ysios, HBM Healthcare Investments, Sunstone Capital, M Ventures, Bristol-Myers Squibb, Maverick Ventures, Seventure and SEED Capital.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access